Clinical Trial Update: Docetaxel in Non Small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

An update on a Phase 2 trial of docetaxel for non-small cell lung cancer; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Taxotere (docetaxel)

Snippet

Sponsor: Sanofi | Conditions: Carcinoma, Squamous Cell | Phase 2 | Status: COMPLETED